Increased expression levels of p53 correlate with good response to cisplatin-based chemotherapy in non-small cell lung cancer.

  • Authors:
    • F Oshita
    • K Nishio
    • Y Kameda
    • A Mitsuda
    • M Ikehara
    • G Tanaka
    • K Yamada
    • I Nomura
    • K Noda
    • H Arai
    • H Ito
    • H Nakayama
  • View Affiliations

  • Published online on: November 1, 2000     https://doi.org/10.3892/or.7.6.1225
  • Pages: 1225-1233
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In order to determine whether expression of the tumor suppressor gene p53 in non-small cell lung cancer (NSCLC) correlates with chemotherapeutic response, resected tumors from 18 patients with recurrent lung cancer who had undergone complete resection and received chemotherapy after the initial tumor recurrence were subjected to p53 immunostaining. Histological examination of the resected tumors revealed 11 adenocarcinomas, 6 squamous cell carcinomas and one adenosquamous cell carcinoma. Group 1 was 50% (n=9) p53-immunopositive. All patients received cisplatin-based chemotherapy after recurrence. No patient in group 1 achieved response to chemotherapy whereas 2 and 3 in group 2 achieved complete and partial responses, respectively. The chemotherapy response rate of group 2 (56%) was significantly higher than that of group 1 (0%, p=0.009). The times to reoccurrence after tumor resection of group 2 was significantly better than that of group 1 (log-rank p=0.019, Wilcoxon p=0.042), and survival after chemotherapy of group 2 was also significantly better than that of group 1 (log-rank p=0.023, Wilcoxon p=0.034). It is suggested that high p53 expression levels in tumors correlate with both good response to cisplatin-based chemotherapy and good survival of patients with advanced NSCLC.

Related Articles

Journal Cover

Nov-Dec 2000
Volume 7 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Oshita F, Nishio K, Kameda Y, Mitsuda A, Ikehara M, Tanaka G, Yamada K, Nomura I, Noda K, Arai H, Arai H, et al: Increased expression levels of p53 correlate with good response to cisplatin-based chemotherapy in non-small cell lung cancer.. Oncol Rep 7: 1225-1233, 2000
APA
Oshita, F., Nishio, K., Kameda, Y., Mitsuda, A., Ikehara, M., Tanaka, G. ... Nakayama, H. (2000). Increased expression levels of p53 correlate with good response to cisplatin-based chemotherapy in non-small cell lung cancer.. Oncology Reports, 7, 1225-1233. https://doi.org/10.3892/or.7.6.1225
MLA
Oshita, F., Nishio, K., Kameda, Y., Mitsuda, A., Ikehara, M., Tanaka, G., Yamada, K., Nomura, I., Noda, K., Arai, H., Ito, H., Nakayama, H."Increased expression levels of p53 correlate with good response to cisplatin-based chemotherapy in non-small cell lung cancer.". Oncology Reports 7.6 (2000): 1225-1233.
Chicago
Oshita, F., Nishio, K., Kameda, Y., Mitsuda, A., Ikehara, M., Tanaka, G., Yamada, K., Nomura, I., Noda, K., Arai, H., Ito, H., Nakayama, H."Increased expression levels of p53 correlate with good response to cisplatin-based chemotherapy in non-small cell lung cancer.". Oncology Reports 7, no. 6 (2000): 1225-1233. https://doi.org/10.3892/or.7.6.1225